Patent application number | Description | Published |
20090023638 | SPILL RESISTANT ANTIBIOTIC FORMULATIONS - The disclosure is directed to a pharmaceutical kit with a first set, a second set and a third set of components. The first set of components can be a carbomer in an aqueous vehicle, the second set of components can be an antibiotic, and the third set of components can be a neutralizing agent. In exemplary embodiments, the first, second and third sets of components can be mixed together to form a spill resistant composition. | 01-22-2009 |
20090247575 | STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS - The present invention relates to a pharmaceutical composition for oral administration comprising an exceptionally labile active agent, a stabilizing vehicle comprising liquid triglycerides and a desiccant, wherein the composition is storage stable for an extended period without substantial degradation of the active agent. | 10-01-2009 |
20100261748 | STABLE LORATADINE SPILL RESISTANT FORMULATION - The present invention provides for a storage stable pharmaceutical liquid suspension for oral administration having a pharmaceutically effective amount of an antihistamine. The storage stable suspension preferably contains loratadine. The present invention further provides a process of preparing the storage stable pharmaceutical liquid suspension as well as a method of treating a mammal with a therapeutically effective amount of loratadine in the stable pharmaceutical liquid suspension. | 10-14-2010 |
20100324007 | ORAL SUSPENSION OF PREDNISOLONE ACETATE - The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation. | 12-23-2010 |
20120065182 | STABILIZING COMPOSITIONS FOR ANTIBIOTICS AND METHODS OF USE - The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v). | 03-15-2012 |
20120238534 | ORAL SUSPENSION OF PREDNISOLONE ACETATE - The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation. | 09-20-2012 |
20130143853 | ORAL SUSPENSION OF PREDNISOLONE ACETATE - The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation. | 06-06-2013 |
20130237512 | STABILIZING COMPOSITIONS FOR ANTIBIOTICS AND METHODS OF USE - The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v). | 09-12-2013 |